Oklahoma City/ Science, Tech & Medicine

Edmond Surgeon's New Thumb Implant Gets Patients Back to Work in Six Weeks

AI Assisted Icon
Published on November 20, 2026
Edmond Surgeon's New Thumb Implant Gets Patients Back to Work in Six WeeksThumb Arthritis X-ray
Towfiqu barbhuiya / Unsplash

At Mercy Clinic Hand Surgery in Edmond, Dr. Sylvia Gray sees at least five patients a day whose thumbs ache at the base joint, a telltale sign of thumb carpometacarpal arthritis. For some of those patients, she's now reaching for a new tool: a ball-and-socket implant that she says lets the thumb keep its natural range of motion instead of sacrificing it to relieve the pain.

Thumb carpometacarpal arthritis, often shortened to CMC arthritis, develops when cartilage and tissue at the base of the thumb break down, according to KOSU. As the bones rub against each other, patients experience pain, stiffness and difficulty gripping objects. Older adults, particularly women, typically develop the condition, and the station notes the thumb itself moves in three directions, which is part of what makes the joint tricky to repair surgically.

From Splints to Surgery

Gray recommends surgery for severe cases only after nonsurgical options like splints and medications fail to preserve finger function, the station's report states. Traditional treatment for CMC arthritis has long involved removing a small wrist bone called the trapezium and using nearby tendons to support the joint, a procedure that can leave patients with decreased grip strength and a recovery stretching for months.

The device Gray now offers some patients, the KeriMedical Touch CMC 1 Prosthesis, works differently. She inserts the ball-and-socket device directly into the patient's bone, which allows the thumb to retain its normal range of motion rather than relying on tendon reconstruction. Recovery timelines still vary from patient to patient, per the same account, but Gray said the procedure can help people resume daily activities sooner than traditional surgery.

Back to Work Within Weeks

Some of Gray's patients, including construction workers and farmers, have returned to work within six weeks of receiving the implant, she said. “It's a game changer,” Gray said, describing the difference it has made for patients whose livelihoods depend on functional hands.

Surgeons in Europe have performed the same implant procedure for roughly the last decade, and Gray described its failure rate there as low, though the dossier for this story did not independently verify that outcome data. Gray was part of one of the first U.S. cohorts trained on the procedure and performs it at Mercy Clinic Hand Surgery in Edmond. She has since performed approximately 45 of the procedures at Mercy Clinic Hand Surgery, part of a national tally that reached nearly 1,200 completed procedures as of July, according to Gray.

A Wide Gap Between the U.S. and Europe

The numbers reveal a stark transatlantic divide in how often surgeons reach for implants over traditional techniques. Gray said implants accounted for less than 2% of U.S. surgeries for CMC arthritis before 2026, compared with more than 80% of CMC surgeries in Europe. The device received approval from the U.S. Food and Drug Administration in 2025, and an excerpt from the agency's device documentation lists a July 10, 2025 indication for primary total joint replacement of the first carpometacarpal joint, though the available excerpt does not spell out the full labeling details.

Early peer-reviewed research offers a cautious but encouraging picture. One study found level II evidence that CMC joint replacement leads to faster recovery than the traditional trapeziectomy procedure during the first three months after surgery, with newer dual-mobility implants associated with trends toward quicker gains in DASH scores and key pinch strength than single-mobility designs, though confidence intervals overlapped considerably and most study arms had high risk of bias, according to a report in PMC. A separate two-year follow-up study of the same type of prosthesis found that 4.5% of patients required implant revision, attributing two of those revisions to cup dislocation after misplacement and two to impingement, per a report in PMC. A third analysis published on PubMed put the short-term complication rate for the Touch device at 2.7%, including a single dislocation, one case of impingement on bone overgrowth, two cases of cup loosening and one case of a related wrist joint arthritis.

Limits Patients Should Know

Gray is upfront about the implant's limitations. The devices need replacing every 10 to 15 years, she said, and they could dislocate if forced to carry more than 20 pounds of weight, a restriction that matters for patients whose jobs involve heavy lifting. She encourages patients with severe arthritis to ask their own doctors whether the implant is a good fit, weighing it against less invasive options first.

Even with those caveats, Gray expects implant surgery to become the new standard in the U.S. as more surgeons receive training in the technique, closing the gap with Europe's long head start on the procedure.